>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • NFLX +10.1%, RMD +9.8%, ATI +8.9%, PIXY +6.1%, LOGI +5.6%, LPL +4.7%, OKE +4.4%, AMTD +2.4%, ADBE +2.4%, KMB +2.2%, STLD +2%, TRV +1.4%, VZ +1%, STT +0.9%, JNJ +0.8%
M&A news:
  • HBIO +7.7% (to acquire 100% of the outstanding stock of Data Sciences International for approximately $70 million; updates guidance)
Select solar related names showing strength:
  • RGSE +37.4%, VSLR +9.9%, RUN +6%, FSLR +3.7%, TAN +2.7%, SOL +0.7%
Other news:
  • AMRN +8.7% (says REDUCE-IT cardiovascular outcomes study reaches 90% mark for reported primary events)
  • BLRX +8.5% (announces that AGI-134, an immunotherapy compound in development for the treatment of multiple solid tumors, demonstrated successful results in two pre-clinical melanoma studies)
  • CCXI +6.5% (announces 'positive' overall survival results with CCR2 Inhibitor CCX872 for locally advanced/metastatic pancreatic cancer)
  • TSRO +5.5% (continued strength - being attributed to M&A speculation following CELG/JUNO, BIVV/SNY news)
  • TGI +5.2% (Triumph Group signs agreement with Boeing to provide major structural assemblies for the 767 program)
  • VYGR +3.8% (announces FDA clearance of IND application for VY-AADC for advanced Parkinson's disease)
  • WHR +3.3% (U.S. Trade Representative Robert Lighthizer confirmed that President Trump approved recommendations to impose safeguard tariffs on imported large residential washing machines and imported solar cells and modules)
  • TSLA +1.4% (announces new 10-year CEO performance award for Elon Musk )
  • FL +1.1% (made a strategic investment in Carbon38)
Analyst comments:
  • CRSP +7.9% (upgraded to Buy from Hold at SunTrust)
  • ATUS +3.4% (upgraded to Overweight from Equal Weight at Barclays)
  • LITE +2% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
  • DKS +1.7% (upgraded to Positive from Neutral at Susquehanna)
  • GGG +1.4% (upgraded to Buy from Hold at Deutsche Bank)
  • PANW +1.3% (upgraded to Buy from Hold at Deutsche Bank)
  • NTR +1.1% (upgraded to Buy from Neutral at Citigroup)